No, didn't attend. I wonder how much Peter Francis discussed Gradalis. Hope it's a good sign that they're listed with those who have already signed up.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%